Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in Taiwan

被引:1
|
作者
Ou, Shi-Chen [1 ,2 ]
Huang, Sheng-Teng [1 ,3 ,4 ,5 ]
Lin, Mei-Chen [6 ]
Chen, Wen-Chi [7 ,8 ]
Huang, Chi-Ping [7 ,9 ]
Lin, Hung-Jen [1 ,2 ]
机构
[1] China Med Univ Hosp, Dept Chinese Med, 2 Yude Rd, Taichung 404, Taiwan
[2] China Med Univ, Sch Post Baccalaureate Chinese Med, Taichung, Taiwan
[3] China Med Univ, Sch Chinese Med, Taichung, Taiwan
[4] China Med Univ Hosp, Canc Res Ctr Tradit Chinese Med, Dept Med Res, Taichung, Taiwan
[5] China Med Univ, Nan Hosp, Tainan, Taiwan
[6] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[7] China Med Univ Hosp, Dept Urol, Taichung, Taiwan
[8] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
[9] China Med Univ, Sch Med, Taichung, Taiwan
关键词
benign prostatic hyperplasia; Chinese herbal medicine; Ji-Sheng-Shen-Qi-Wan; National Health Insurance Research Database; retrospective cohort study; URINARY-TRACT SYMPTOMS; DOUBLE-BLIND; MEN; DUTASTERIDE; FINASTERIDE; GUIDELINES;
D O I
10.1111/iju.14853
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives Benign prostatic hyperplasia affects elderly males, with progression presenting the risk of urinary complications and eventual surgical intervention. We aimed to evaluate the effects of Chinese herbal medicine in patients with benign prostatic hyperplasia. Methods This retrospective cohort study analyzed claims data in Taiwan's National Health Insurance Research Database from 2001 to 2013. A total of 4142 patients newly diagnosed as benign prostatic hyperplasia were enrolled and divided into cohorts of Chinese herbal medicine users and nonusers by performing 1:1 propensity score matching. The risk of benign prostatic hyperplasia-related complications was assessed by the Cox proportional hazard model. The cumulative incidence of benign prostatic hyperplasia-related surgeries was assessed by Kaplan-Meier method. Results During the study period, the risk of benign prostatic hyperplasia-related complications was lower in the Chinese herbal medicine cohort than non-Chinese herbal medicine cohort with an adjusted hazard ratio of 0.82 (95% confidence interval 0.73-0.92) after controlling for multiple variables. Subgroup analysis revealed that Chinese herbal medicine users had a significantly lower risk of urinary tract infection (adjusted hazard ratio 0.67, 95% confidence interval 0.50-0.89) and urinary retention (adjusted hazard ratio 0.83, 95% confidence interval 0.72-0.97). In addition, Chinese herbal medicine users also had a lower incidence rate of benign prostatic hyperplasia-related surgery (32.14 vs 40.20, adjusted hazard ratio 0.74, 95% confidence interval 0.61-0.89) and a longer surgery-free interval than non-Chinese herbal medicine users (3.98 vs 3.00 mean person-year, P < 0.001). Data revealed Salviae miltiorrhizae and Ji-Sheng-Shen-Qi-Wan as the most commonly prescribed Chinese herbal medicine by traditional Chinese medicine practitioners. Conclusions Our study demonstrated that Chinese herbal medicine might have effects in the benign prostatic hyperplasia-related complications and surgeries in patients with benign prostatic hyperplasia.
引用
收藏
页码:623 / 630
页数:8
相关论文
共 50 条
  • [1] Editorial Comment to Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in Taiwan
    Sekido, Noritoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (07) : 631 - 631
  • [2] The effects of a Chinese herbal medicine (VGHBPH0) on patients with benign prostatic hyperplasia: A pilot study
    Yeh, Hsin-Fu
    Li, Tsai-Feng
    Tsai, Cheng-Hung
    Wu, Pei-Wen
    Huang, Yi-Hsiu
    Huang, William J.
    Chen, Fun-Jou
    Hwang, Shinn-Jang
    Chen, Fang-Pey
    Wu, Ta-Peng
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (10) : 967 - 971
  • [3] Cernitol Herbal medicine for benign prostatic hyperplasia
    不详
    ACTUALITES PHARMACEUTIQUES, 2020, 59 (592): : 10 - 10
  • [4] Mechanisms and Efficacy of Chinese Herbal Medicines in Benign Prostatic Hyperplasia
    WANG Fu
    MA Dongyue
    YANG Jiutian
    LYU Dongfang
    GAO Qinghe
    LI Chunlei
    ZHONG Chongfu
    Chinese Journal of Integrative Medicine, 2025, 31 (01) : 73 - 82
  • [5] Mechanisms and Efficacy of Chinese Herbal Medicines in Benign Prostatic Hyperplasia
    Wang, Fu
    Ma, Dong-yue
    Yang, Jiu-tian
    Lyu, Dong-fang
    Gao, Qing-he
    Li, Chun-lei
    Zhong, Chong-fu
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2025, 31 (01) : 73 - 82
  • [6] Chinese herbal medicine may reduce major adverse cardiovascular events in patients with dialysis hypotension: A taiwan nationwide cohort study
    Tsai, Ming-Yen
    Huang, Po-Yu
    Lee, Wen-Chin
    Cheng, Ben-Chung
    Tsai, Fuu-Jen
    Liu, Chun-Ting
    JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE, 2024, 14 (05): : 550 - 557
  • [7] Chinese Herbal Medicine Is Helpful for Survival Improvement in Patients With Multiple Myeloma in Taiwan: A Nationwide Retrospective Matched-Cohort Study
    Huang, Chia-Yu
    Wu, Mei-Yao
    Kuo, Yu-Hung
    Tou, Sio-Ian
    Yen, Hung-Rong
    INTEGRATIVE CANCER THERAPIES, 2020, 19
  • [8] Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: systematic review of randomized controlled trials
    Ma, Chun Ho
    Lin, Wai Ling
    Lui, Sing Leung
    Cai, Xun-Yuan
    Wong, Vivian Taam
    Ziea, Eric
    Zhang, Zhang-Jin
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (04) : 471 - 482
  • [9] To explore the effects of herbal medicine among cancer patients in Taiwan: A cohort study
    Li, Tsai-Feng
    Hwang, I-Hsuan
    Tsai, Cheng-Hung
    Hwang, Shinn-Jang
    Wu, Ta-Peng
    Chen, Fang-Pey
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (08) : 767 - 774
  • [10] Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study
    Hung, Kuo-Feng
    Hsu, Ching-Ping
    Chiang, Jen-Huai
    Lin, Hung-Jen
    Kuo, Yi-Ting
    Sun, Mao-Feng
    Yen, Hung-Rong
    JOURNAL OF ETHNOPHARMACOLOGY, 2017, 199 : 168 - 174